
Am J Psychiatry 1980; 137:16-21
Copyright © 1980 by American Psychiatric Association
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
G Chouinard and BD Jones
Tardive dyskinesia is thought to result from neostriatal dopaminergic
receptor supersensitivity induced by chronic treatment with neuroleptics.
The authors suggest that dopaminergic supersensitivity also occurs in the
mesolimbic region after chronic neuroleptic exposure, resulting in the
development of a supersensitivity psychosis. Neuroleptic-induced
supersensitivity psychosis is illustrated by data from 10 patients that
demonstrate the syndrome's clinical and pharmacologic characteristics. An
implication of neuroleptic-induced mesolimbic supersensitivity is that the
tenaency toward psychotic relapse in such patients is determined by more
than just the normal course of the illness.
This article has been cited by other articles:

|
 |

|
 |
 
A.-N. Samaha, P. Seeman, J. Stewart, H. Rajabi, and S. Kapur
"Breakthrough" Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time
J. Neurosci.,
March 14, 2007;
27(11):
2979 - 2986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chouinard
The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs
Focus,
September 1, 2006;
4(4):
528.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Bola
Psychosocial Acute Treatment in Early-Episode Schizophrenia Disorders
Research on Social Work Practice,
May 1, 2006;
16(3):
263 - 275.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. ROSS
Clozapine and Typical Antipsychotics
Am J Psychiatry,
October 1, 2004;
161(10):
1925 - 1926.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tranter and D. Healy
Neuroleptic discontinuation syndromes
J Psychopharmacol,
January 1, 1998;
12(4):
401 - 406.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Lieberman, D. Jody, J. Ma. J. Alvir, M. Ashtari, D. L. Levy, B. Bogerts, G. Degreef, D. I. Mayerhoff, and T. Cooper
Brain Morphology, Dopamine, and Eye-Tracking Abnormalities in First-Episode Schizophrenia: Prevalence and Clinical Correlates
Arch Gen Psychiatry,
May 1, 1993;
50(5):
357 - 368.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Gualtieri, S. R. Schroeder, R. E. Hicks, and D. Quade
Tardive Dyskinesia in Young Mentally Retarded Individuals
Arch Gen Psychiatry,
April 1, 1986;
43(4):
335 - 340.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gardos, J. O. Cole, R. M. Rapkin, R. A. LaBrie, E. Baquelod, P. Moore, R. Sovner, and J. Doyle
Anticholinergic Challenge and Neuroleptic Withdrawal: Changes in Dyskinesia and Symptom Measures
Arch Gen Psychiatry,
November 1, 1984;
41(11):
1030 - 1035.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1980
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|